ABSTRACT. Poor growth is a common feature of symptomatic children (Centers for Disease Control stage P2) infected with human immunodeficiency virus-1 (HIV-1). However, several previous studies have failed to show any relationship between serum hormone levels and poor growth. To assess the roles of hormone deficiency and hormone resistance in the development of poor growth in HIV-1-infected children, we studied six asymptomatic Centers for Disease Control stage P I [height SD score = 0.01 + 1.0 (mean 2 SD)], 10 P2 (height SD score = -2.0 + 1.0), and six short, normal children (height S D score = -2.4 + 1.2). Mean weighkheight SD scores were similar in all three groups, suggesting that gross nutritional status did not differ between groups. There were no significant differences between groups with respect to mean plasma levels of IGF-I, thyroid hormones, TSH, and cortisol. As an index of hormone sensitivity, we quantified in vhro colony formation of erythroid progenitor cells, isolated from peripheral blood of study subjects, in response to IGF-I, growth hormone (GII), and insulin. 1' 2 subjects hnd a quantitative mean reduction in erythroid progenitor cells colony formation in response to IGF-I of 32% compared with PI subjects ( p = 0.001 by analysis of variance) and 21% compared with controls (p = 0.006); in rcsponsc to GH of 21% compared with controls (p = 0.015); and in response to insulin of 35% compared with PI subjects (p = 0.038) and 34% compared with controls ( p = 0.004). Similar qualitative differences (changes in shape) of the three hormone response curves between P2 and P1 and P2 and control subjects were observed. No differences in either quantitative or qualitative erythroid progenitor cells responses to IGF-I, GH, or insulin between P1 and control subjects were observed. We conclude that more severe HIV-1 infection in children is associated with in vitro resistance to the growth-promoting actions of IGF-I, GH, and insulin that is unrelated to the presence of gross malnutrition, differences in hematologic status, or over-
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ABSTRACT. Poor growth is a common feature of symptomatic children (Centers for Disease Control stage P2) infected with human immunodeficiency virus-1 (HIV-1). However, several previous studies have failed to show any relationship between serum hormone levels and poor growth. To assess the roles of hormone deficiency and hormone resistance in the development of poor growth in HIV-1-infected children, we studied six asymptomatic Centers for Disease Control stage P I [height SD score = 0.01 + 1.0 (mean 2 SD)], 10 P2 (height SD score = -2.0 + 1.0), and six short, normal children (height S D score = -2.4 + 1.2). Mean weighkheight SD scores were similar in all three groups, suggesting that gross nutritional status did not differ between groups. There were no significant differences between groups with respect to mean plasma levels of IGF-I, thyroid hormones, TSH, and cortisol. As an index of hormone sensitivity, we quantified in vhro colony formation of erythroid progenitor cells, isolated from peripheral blood of study subjects, in response to IGF-I, growth hormone (GII), and insulin. 1' 2 subjects hnd a quantitative mean reduction in erythroid progenitor cells colony formation in response to IGF-I of 32% compared with PI subjects ( p = 0.001 by analysis of variance) and 21% compared with controls (p = 0.006); in rcsponsc to GH of 21% compared with controls (p = 0.015); and in response to insulin of 35% compared with PI subjects (p = 0.038) and 34% compared with controls ( p = 0.004). Similar qualitative differences (changes in shape) of the three hormone response curves between P2 and P1 and P2 and control subjects were observed. No differences in either quantitative or qualitative erythroid progenitor cells responses to IGF-I, GH, or insulin between P1 and control subjects were observed. We conclude that more severe HIV-1 infection in children is associated with in vitro resistance to the growth-promoting actions of IGF-I, GH, and insulin that is unrelated to the presence of gross malnutrition, differences in hematologic status, or over-whelming illness. This resistance to IGF-I could contribute to the poor in vivo growth seen in symptomatic HIV- Whereas infants and children currently constitute 2% of recognized cases of AIDS in the United States (I), the incidence of HIV-1 infection in this population is rising dramatically. As of July 1990,2464 children <13 y of age met CDC criteria for the diagnosis of AIDS (2). However, from 1988 to 1989, the incidence of AIDS in women and in their offspring increased more rapidly than in any other cohorts; revised predictions suggest that there will be an additional 10000 to 20000 cases of PAIDS in the next few years (3).
The clinical course of infants with vertically transmitted AIDS generally follows one of two paths (4). Approximately 20% of children infected with HIV-1 develop symptoms in the 1st y of life, with Pnetlmocystis carinii pneumonia the dominant illness in this group. The more common presentation is late in onset with an asymptomatic period for years. Overt HIV-1 disease develops at a rate of -8%/y, with a median incubation period of 4.8 y; by age 10 y, almost all infected children will manifest symptoms (5). Growth retardation, specifically FTT, is a common feature of PAIDS (6), regardless of whether it is acquired by vertical transmission or by transfusion, and is one criterion used to define CDC stage P2 (Table 1 ) (4). The mechanism for FTT in PAIDS is unknown, although it has been linked to associated malnutrition, hormonal deficiencies, and ovenvhelming illness (6). However, based on our results from an in vitro ) 
MATERIALS AND METHODS

Patients.
The study cohort consisted of six asymptomatic PI children (three F/three M), 10 symptomatic P2 children (four F/ six M), and six short, normal children (two F/four M). Eight PAIDS patients had presumed vertical transmission of their disease based on maternal history (three PI and five P2), and eight patients became infected after transfusions (three PI and five P2). All subjects were studied as outpatients. Two PI and nine P2 subjects were receiving AZT. No P2 subject was acutely ill at the time of study or had had repeated opportunistic infections. P-staging was according to standardized CDC criteria (4). Short, normal children were, on average, 2.4 zk 1.2 (range = 0.6-4. I) SD scores (7) below the mean height for age and had either normal thyroid function tests, normal stimulated serum GH levels, and/or normal height velocity. Most patients also had CBC and chemistry panels performed on or near the day of study. All studies were performed with the informed consent and/or assent of the patient and/or his or her parents under a protocol approved by the UCLA Human Subject Protection Committee.
Hormone Assays. Plasma T4, T3, reverse T3, TSH, and cortisol levels were measured between 0800 and 1 I00 h by standard RIA. Plasma IGF-I concentrations were determined after acid-ethanol extraction to remove endogenous IGF-BP. IGF-I levels were normalized for chronologic age by conversion to SD scores (bone ages were not available for children with PAIDS). All hormonal measurements were performed in single assays at Endocrine Sciences Laboratories (Calabasas Hills, CA).
In Vitro Colony Formation of EPC in Response to Stimulation witlt Hormones. The methodology of the colony-forming assay for EPC is outlined below (8,9). Two 10-mL samples of venous blood were collected in preservative-free sterile heparin, and buffy coat cells were separated by centrifugation. EPC were cultured in microtiter plates. Data Analysis. Clinical data are presented as mean f SD.
Statistical significance of differences in height, weight, and height:weight SD score, and of CBC and chemistry parameters, serum hormone concentrations, and baseline EPC colony counts between groups, was determined by t test. EPC data are presented as mean f SEM to preserve graphic clarity. Repeated-measures analysis of variance was used to evaluate differences in colony count versus concentration curves among the PI, P2, and short control groups. To accommodate missing data and departures from the usual sphericity assumption, program BMDP5V (BMDP Statistical Software, Inc., Los Angeles, CA) was used to assess group effects and interactions (12). Within each analysis, the Akaike criterion was used to choose among compound symmetry, generalized autoregressive, or full parameterization as the most appropriate covariance model. Two sets of repeated-measures analysis of variance were performed for each of the hormone stimulation studies (IGF-I, GH, or insulin), one to test for qualitative differences in the pattern of stimulation and the second to quantify overall changes in percentage of stimulation. In the first analyses, the dependent variable was the logarithm of the absolute colony count (log count). If differences between curves among PI, P2, and control groups were due only to differences in the baseline number of recovered progenitor cells, the curves would be similar in overall shape and only displaced vertically from one another. Therefore, to test for differences in intrinsic res~onsiveness to hormone. we looked for differences in shape (e.g. slope or lack of superimposabi~it~) of the log count versus concentration curves. Differences in shape indicate that the curves are not superimposable even after correcting for baseline differences in colony counts. Specifically, p values for overall differences in shape were computed by Wald tests for the interaction between group and concentration effects. In the second analyses, changes in responsiveness were quantified by comparing the logarithm of the relative colony counts (expressed as a fraction of the colony count observed at zero concentration). In these analyses, the magnitude of the overall differences in stimulation was assessed by the sizes of the grouping effects (i.e. the mean differences in relative colony counts) and their Wald test p values.
RESULTS
Patient Clinical C/taracteristics. The mean age of P2 patients was younger than that of either the PI (p < 0.001) or control subjects (p < 0.01) ( Table 2 ). The mean height of P2 patients was shorter than that of PI patients ( p < 0.001), but similar to that of the short, normal controls. The short, normal controls were also shorter than PI subjects ( p < 0.00 I). The mean weight of P2 patients was less than that of PI patients ( p < 0.001), but was greater than that of the controls ( p < 0.02). The short, normal controls also weighed less than PI subjects (p < 0.001).
The mean weight:height SD scores were similar among the groups. Equivalency in nutritional status was further supported by lack of difference in concentrations of serum albumin, urea nitrogen, creatinine, and calcium between groups (Table 3 ). In addition, there were no differences in Hb, hematocrit, mean corpuscular Hb, mean corpuscular Hb concentration, mean corpuscular volume, and erythrocyte count between PI and P2 subjects and between PI subjects and short controls. Statistically significant, albeit mild, differences in Hb, hematocrit, mean corpuscular Hb concentration, mean corpuscular volume, and erythrocyte count between P2 subjects and short controls were observed (Table 3) .
Plasma Hormone Concentrations. There were no statistically significant mean differences observed in thyroid function tests (T4, T3, and reverse T3), TSH, or IGF-I levels (as in index of G H sufficiency) between PI, P2, and control groups (Table 4) . Additionally, mean basal plasma cortisol levels did not differ significantly between groups. Failure to observe differences between groups in plasma IGF-I, reverse T3, and cortisol levels also t IGF-I levels were normalized for chronologic age by conversion to SD scores.
suggests that there were no gross or subtle nutritional differences between groups.
In Vitro Hormone Responsiveness. General. Eight EPC studies of six P1 subjects, 11 studies of 10 P2 subjects, and six studies (one each) of six short, normal control subjects were performed. For those subjects studied on two occasions, mean responsiveness is reported.
IGF-I. Basal colony counts (without added hormone) for
experiments with IGF-I were 98.0 + 43 (PI), 52.6 + 25 (P2), and 41.8 f 10.5 (control); P1 versus P2 (p < 0.02), PI versus control ( p < 0.01), and P2 versus control ( p = NS). The overall shape of the EPC colony formation curve of P2 subjects in response to direct IGF-I stimulation was qualitatively different from that of P1 subjects and that of controls (both p < 0.00 1).
The shapes of the curves for P1 subjects and controls were comparable and were superimposable after correcting for differences in baseline colony counts ( p = 0.1) (Fig. IA , absolute data). P2 subjects had a significant mean reduction in EPC colony formation in response to IGF-I of 32% compared with P1 subjects ( p = 0.001) and of 21% compared with controls ( p = 0.006). There was no statistically significant difference between P1 subjects and controls ( p = 0.67) (Fig. 1 B, 0.057). The shapes of the'curves for PI subjects a r k con'irols were similar ( p = 0.72) (Fig. 2.4 , absolute data). P2 subjects had a significant mean reduction in EPC colony formation in response to GH of 2 1 % compared with controls (p = 0.01 5). P2 subjects had a mean reduction in EPC colony formation in response to G H of 16% compared with P1 subjects (p = 0.128). There was no statistically significant difference between PI subjects and controls ( p = 0.42) (Fig. 2B, relative control ( p = NS). The overall shape of the EPC colony formation curve of P2 subjects in response to insulin was qualitatively different compared with that of PI subjects ( p = 0.007) and that of controls ( p = 0.001). The shapes of the curves for P1 subjects and controls were similar (p = 0.69) (Fig. 3A , absolute data). P2 subjects had a significant mean reduction in EPC colony formation in response to insulin stimulation of 35% compared with P1 subjects (p = 0.038) and of 34% compared with controls ( p = 0.004); there was no statistically significant difference between P1 subjects and controls (p = 0.47) (Fig. 3B, relative data) . Effects ofAZT. Because many of the PAIDS patients (both P1 and P2) were on AZT at the time of study, the in vitro effect of AZT incubation [at either 2 or 5 pM (therapeutic serum concentrations)] on normal EPC responsiveness to IGF-I, GH, and insulin was assessed. Neither concentration of AZT induced significant blunting of EPC responsiveness to any of the three growth factors (data not shown).
DISCUSSION
Resistance to IGF-I, GH, and other growth factors has been previously suggested as a potential cause for growth failure in children with AIDS (13, 14) . Such resistance can result from IGF-1 (pglL) Fig. 1 . EPC responsiveness to IGF-I. A, Absolute data. The overall shape of the EPC colony formation curve of P2 subjects in response to direct IGF-I stimulation was qualitatively different compared with that of PI subjects and controls (both p < 0.001). The shapes of the curves for P1 subjects and controls were similar ( p = 0.1); i.e. the slopes were comparable and the curves were superimposable after correcting for baseline differences. The ordinate is on a log scale and represents the absolute number of erythroid colonies formed in response to increasing concentrations of IGF-I. The abscissa here and in B represents the concentrations of added IGF-I (pg/L). The data here and in the subsequent two figures are presented as the mean k SEM of the log counts.
Key for this and the subsequent two figures: PI, asymptomatic HIV-Iinfected children; P2, symptomatic HIV-I-infected children [specific Pstaging criteria based on standardized CDC criteria (4); see Table I ]; sllort controls, short, endocrinologically normal children. B, Relative data. P2 subjects had a significant mean reduction in EPC colony formation in response to direct IGF-I stimulation of 32% compared with PI subjects ( p = 0.00 1) and of 2 1 % compared with controls ( p = 0.006); there was no statistically significant difference between PI subjects and controls ( p = 0.67). The unstimulated number of EPC colonies (referred to, on the ordinate, as colonies) formed in incubation mixtures without added IGF-I is defined as 100%.
prereceptor, receptor-binding, or post-receptor-binding abnormalities. In the current study, we have shown that symptomatic children with AIDS (CDC stage P2) demonstrate marked in vitro resistance to the growth-promoting action of IGF-I compared with asymptomatic (PI) children with AIDS and compared with equally short, otherwise normal children. The P2 children also manifested a statistically significant reduction in in vitro responsiveness to the growth-promoting action of GH compared with short controls. Compared with P1 children, responsiveness of P2 Fig. 2 . EPC responsiveness to GH. A, Absolute data. The overall shape of the EPC colony formation curve of P2 subjects in response to G H stimulation was qualitatively different compared with that ofcontrols ( p = 0.009) and showed a borderline difference compared with that of PI subjects ( p = 0.057). The shapes of the curves for PI subjects and controls were similar ( p = 0.72). The ordinaie is on a log scale and represents the absolute number of erythroid colonies formed in response to increasing concentrations of GH. The abscissa here and in B represents the concentrations of added GH (pg/L). B, Relative data. P2 subjects had a significant mean reduction in EPC colony formation in response to G H of 21% compared with controls ( p = 0.015). P2 subjects had a mean reduction in EPC colony formation in response to G H of 16% compared with PI subjects ( p = 0.128). There was no statistically significant difference between PI subjects and controls ( p = 0.42). The unstimulated number of erythroid progenitor cell colonies (referred to, on the ordinate, as colonies) formed in incubation mixtures without added G H is defined as 100%.
children to GH showed a borderline reduction. Because the effect of GH on normal erythropoiesis appears to be mediated through local IGF-I production and action (1 5 ) , one might expect there to be GH resistance in situations in which there is IGF-I resistance. As a paradigm for this interaction, both GH and IGF-I resistance have been described in association with protein malnutrition in rats (16, 17) . In addition, statistically significant resistance to the mitogenic action of insulin was observed in P2 subjects compared with both P1 subjects and controls. The statistically significant findings of resistance to the growth-promoting actions of IGF-I, GH, and insulin were evident regardless of whether logs of the absolute count (changes in shape) or relative data (quantitative) were analyzed.
The observed differences in basal colony formation between GEFFNER ET AL. Insulin (pmol/L x lo3) Fig. 3 . EPC responsiveness to insulin. A, Absolute data. The overall shape of the EPC colony formation curve of P2 subjects in response to insulin stimulation was qualitatively different compared with that of PI subjects (p = 0.007) and controls (p = 0.001). The shapes of the curves for PI subjects and controls were similar (p = 0.69). The ordinate is on a log scale and represents the absolute number of erythroid colonies formed in response to increasing concentrations of insulin. The abscissa here and in Figure 1C represents the concentrations of added insulin (pmol/L X lo3). R, Relative data. P2 subjects had a significant mean reduction in EPC colony formation in response to insulin stimulation of 35% compared with P1 subjects (p = 0.038) and of 34% compared with controls ( p = 0.004); there was no statistically significant difference between PI subjects and controls (p = 0.47). The unstimulated number of erythroid progenitor cell colonies (referred to, on the ordinate, as colonies) formed in incubation mixtures without added insulin is defined as 100%.
PI patients and the other two groups, although statistically significant, are not likely to account for differences in stimulatory responses based on previous studies from our laboratory; furthermore, there were no significant differences in basal colony formation between P2 subjects and controls, yet there were significant differences in responsiveness to all three growth factors. It is unclear why P1 subjects had significantly higher basal colony counts compared with the other two groups. Although P2 and control subjects had a similar degree of growth failure, short stature per se is not associated with lower basal colony counts (1 8). Furthermore, we have shown in this study that AZT treatment does not influence the magnitude of EPC colony formation in response to IGF-I, GH, or insulin. The observed differences in IGF-I responsiveness between P2 subjects and short controls are also not likely to be due to minor differences in the erythroid status between these two groups in view of similar differences in IGF-I responsiveness between P1 and P2 subjects whose erythroid parameters were statistically indistinguishable.
Recently, Laurence et al. (19) have shown that GH, depending on the concentration used, enhances HIV-1 replication in acutely infected peripheral blood mononuclear cells as measured by p24 antigen production, cellular proliferation (['Hlthymidine incorporation), and TNF-a production. However, in the same study, a clone of chronically HIV-1-infected promonocytic cells, sensitive to viral induction by cytokines and protein kinase C activators, was resistant to the effects of G H on p24 antigen production and on HIV-1-associated trans-activation (1 9). If the latent infection is more reflective of in vivo HIV-1 infection, these data would be consistent with our findings of GH/IGF-I resistance.
The IGF-I-resistant P2 patients in this study were significantly shorter than the asymptomatic P1 patients and the short, normal children. We found no differences between groups in thyroid function or in plasma IGF-I levels as an index of GH sufficiency. Low plasma IGF-I levels have been reported frequently, but not always, in children with AIDS (6, 13) and are thought to be the result of associated malnutrition. Gross malnutrition was not likely to be responsible for the IGF-I resistance observed in our P2 subjects inasmuch as their mean weight SD score was similar to that of our IGF-I-sensitive short, normal control group. Whereas sophisticated tests of body composition were not used in this study, lack of difference in various sensitive chemical and endocrinologic measures of nutritional status also suggests that the differences in in vitro hormone responsiveness are not the result of differences in body composition between groups. Nonetheless, a highly selective nutritional deficiency as may occur in AIDS patients (20) cannot be excluded as at least a partial explanation for our observations. Normal serum T4 and T3 levels and normal stimulated G H levels have been reported in most children with AIDS (13, 14). A single child with perinatally acquired HIV-1 infection with well-characterized G H deficiency in the face of poor linear growth velocity and delayed bone age whose height velocity nearly doubled with G H treatment (although to a rate considerably less than is usually seen in other situations associated with G H deficiency) has been described The mechanism by which IGF-I resistance develops could be related to increased production of cytokines, which occurs in patients with AIDS. Specifically, TNF production is increased in some AIDS patients, particularly in the setting of opportunistic infections, progressive encephalopathy, and wasting (22). Whereas IGF-I has been shown to promote human adult and embryonic erythropoiesis, TNF inhibits erythroid colony formation at a concentration of -10 U/mL (23). Chronic TNFinduced inhibition of erythropoiesis has been suggested as a cause for the hypoplastic anemia that occurs in AIDS patients (24). However, IGF-I (10-100 pg/L) promotes cartilage matrix formation (proteoglycan synthesis) equally in the presence or absence of TNF (5-500 pmol/L) (25). Thus, the in vitro cellular resistance to IGF-I demonstrated in our P2 subjects is unlikely to be a TNF-induced epiphenomenon. Other cytokines, e.g. IL-1 and interferon-y, do not appear to exert pronounced inhibitory actions in the above systems. Most recently, elevated serum interferon-a levels have been described in patients with AIDS and have been implicated at least in the hypertriglyceridemia associated with wasting (26). However, none of our P2 subjects was acutely ill and, therefore, their blunted EPC responsiveness to the three growth factors is not likely to be the result of severe intercurrent illness.
One mechanism whereby G H and IGF-I resistance could occur in children with symptomatic AIDS is through the presence of circulating inhibitors of IGF-I action, such as IGF-BP. Six such proteins have now been described, although the majority of IGF in the circulation are associated with a single 150-kD complex known as IGF-BP3, levels of which are strongly GH-dependent (27) . A second, presumably non-GH-dependent IGF-BP is IGF-
